Hospital and healthcare insurance system record–based epidemiological study of myasthenia gravis in southern and northern China-Reference-Cited by-同舟云学术

Hospital and healthcare insurance system record–based epidemiological study of myasthenia gravis in southern and northern China

Published:2020-01-03 Issue:5 Volume:41 Page:1211-1223
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Fang Wei^ORCID,Li Yan,Mo Rong,Wang Jianjian,Qiu Li,Ou Chuangyi,Lin Zhongqiang,Huang Zhidong,Feng Huiyu,He Xuetao,Wang Weizhi,Xu Peipei,Wang Lihua,Ran Hao,Liu Weibin^ORCID

Funder

National Natural Science Foundation of China

Young Scientists Fund

the National Natural Science Foundation Key International (Regional) Cooperation Research Project

the Clinical Study of 5010 Planned Project Sun Yat-sen University

Science and Technology Planned Project of Guangdong in China

2018 Guangdong Province Foundation and Applied Basic Research Special Fund for PhD Research Project Initiation

2016 Pearl River Talents Scheme Fund

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10072-019-04146-1.pdf

Reference47 articles.

1. Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8(5):475–490. https://doi.org/10.1016/S1474-4422(09)70063-8

2. Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B (2014) Diagnostic and clinical classification of autoimmune myasthenia gravis. J Autoimmun 48-49:143–148. https://doi.org/10.1016/j.jaut.2014.01.003

3. Liu FC, Kuo CF, See LC, Tsai HI, Yu HP (2017) Familial aggregation of myasthenia gravis in affected families: a population-based study. Clin Epidemiol 9:527–535. https://doi.org/10.2147/CLEP.S146617

4. Breiner A, Widdifield J, Katzberg HD, Barnett C, Bril V, Tu K (2016) Epidemiology of myasthenia gravis in Ontario, Canada. Neuromuscul Disord 26(1):41–46. https://doi.org/10.1016/j.nmd.2015.10.009

5. Guptill JT, Sharma BK, Marano A et al (2012) Estimated cost of treating myasthenia gravis in an insured U.S. population. Muscle Nerve 45(3):363–366. https://doi.org/10.1002/mus.22327

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology, Patient Characteristics, and Treatment Patterns of Myasthenia Gravis in Taiwan: A Population-Based Study;Neurology and Therapy;2024-04-27

2. Incidence and prevalence of myasthenia gravis in the United States: A claims‐based analysis;Muscle & Nerve;2023-12

3. Diagnosis and therapy of myasthenia gravis—the patients’ perspective: a cross-sectional study;Frontiers in Neurology;2023-08-04

4. Morbidity analysis of verified cases of myasthenia gravis in central Kazakhstan;Medicine and ecology;2023-07-23

5. Epigenome‐wide DNA methylation analysis of myasthenia gravis;FEBS Open Bio;2023-06-10